To enhance our comprehension of the therapeutic mechanism of AR in the management of T2DM, we conducted an analysis of the protein blot to assess the expression levels of RAGE, p38, p-P38, p-AKT, and PI3Kp85 proteins. Here, MAPK1 is linked to type 2 diabetes mellitus.